Kuros Biosciences Is A Biotechnology Company Based In Switzerlandspecializing In Advanced Biologic Technologies For Bone Healing And Spinal Fusionfounded In 2016 Through A Merger Involving Cytos Biotechnology Ltd The Company Operates Globally With Facilities In The Netherlands And The United Stateskuros Is Listed On The Six Swiss Stock Exchange Under The Symbol Kurn The Company Develops Innovative Solutions For Spinal Fusion Surgeriesincluding Magnetosa Synthetic Bone Graft Used In Over 10 000 Procedures Worldwideanother Key Product Is Fibrin Ptha Drug Biologic Combination Currently In Phase 2 Clinical Trials In The U Sfor Enhancing Bone Regenerationkuros Emphasizes Scientific Rigor And Aims To Alleviate The Societal And Economic Burden Of Spine Related Pain Through Its Evidence Based Approach And Ongoing Clinical Trialswith A Commitment To Innovationkuros Actively Participates In Global Medical Conferences And Collaborates With Research Driven Medical Centers
No conferences found for this company.
| Company Name | Kuros Biosciences Ag |
| Country |
Switzerland
|
| Address | N/A |
| Telephone | N/A |
| N/A |
